Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing estradiol valerate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol valerate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol valerate 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol valerate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely estradiol valerate 2 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol valerate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol valerate 20mg/mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol valerate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol valerate 40mg/cc |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol valerate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol valerate 10mg/cc |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol valerate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol valerate 40mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol valerate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol valerate 10mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol valerate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol valerate 20mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol valerate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol valerate 40mg/cc injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol valerate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol valerate + testosterone enanthate 4mg/90mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol valerate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol valerate + testosterone enanthate 4mg/90mg injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol valerate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely estradiol valerate 2 milligram and norethisterone 700 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol valerate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely estradiol valerate 2 milligram and medroxyprogesterone 20 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol valerate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol valerate 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol valerate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol valerate 1 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Estradiol valerate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely estradiol valerate 2 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol valerate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely estradiol valerate 2 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Estradiol valerate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely estradiol valerate 2 milligram and norethisterone 700 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol valerate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely estradiol valerate 2 milligram and norethisterone 700 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Estradiol valerate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely estradiol valerate 2 milligram and norethisterone 700 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Estradiol valerate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely estradiol valerate 2 milligram and medroxyprogesterone 20 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol valerate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely estradiol valerate 2 milligram and medroxyprogesterone 20 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Estradiol valerate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely estradiol valerate 2 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Estradiol valerate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol valerate 1 mg oral tablet |
Has precise active ingredient |
True |
Estradiol valerate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely estradiol valerate 2 milligram and norethisterone 700 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Estradiol valerate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely estradiol valerate 2 milligram and medroxyprogesterone 20 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Estradiol valerate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol valerate 2 mg and medroxyprogesterone acetate 20 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Estradiol valerate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Estradiol valerate 2 mg and medroxyprogesterone acetate 20 mg oral tablet |
Has precise active ingredient |
True |
Estradiol valerate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely estradiol valerate 2 milligram and norethisterone 700 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Estradiol valerate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |